1. Home
  2. RBKB vs ANTX Comparison

RBKB vs ANTX Comparison

Compare RBKB & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RBKB

Rhinebeck Bancorp Inc.

HOLD

Current Price

$15.87

Market Cap

179.0M

Sector

Finance

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.60

Market Cap

170.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBKB
ANTX
Founded
1860
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.0M
170.6M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
RBKB
ANTX
Price
$15.87
$4.60
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
11.4K
214.1K
Earning Date
04-23-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
215.00
32.56
EPS
0.92
N/A
Revenue
$2,984,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$1.00
52 Week High
$17.99
$6.91

Technical Indicators

Market Signals
Indicator
RBKB
ANTX
Relative Strength Index (RSI) 47.49 57.17
Support Level $15.65 $1.06
Resistance Level $16.01 $5.14
Average True Range (ATR) 0.27 0.42
MACD -0.06 -0.05
Stochastic Oscillator 19.99 54.07

Price Performance

Historical Comparison
RBKB
ANTX

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: